Rivastor 9,5 mg/24 timer

Rivastor is a transdermal patch containing the drug rivastigmine, primarily used in the treatment of Alzheimer's disease. The brand is developed by Orion Pharma, a well-established Finnish company specializing in pharmaceuticals. Orion Corporation, its ultimate parent company, is headquartered in Finland and focuses on innovative healthcare solutions. The product is manufactured in multiple countries to meet global demand, ensuring high-quality production standards. Rivastor patches deliver medication steadily over a 24-hour period, enhancing patient compliance and therapeutic effectiveness.